We are proud to be ranked Top 3 in India and among the Top 100 globally in Milestone-1 of the XPRIZE Healthspan Competition, selected from over 2,000 global companies.
The XPRIZE Healthspan is a $101 million global competition focused on advancing age reversal, longevity, and extended healthspan, recognizing organizations that demonstrate transformative potential in healthy aging innovation.
Why Choose Gplife Healthcare?
XPRIZE Validated
Ranked Top 3 in India and Top 100 globally in XPRIZE Healthspan Milestone-1, selected from 2,000+ global innovators in longevity and age-reversal science.
Science-Driven Longevity
Our programs are built on evidence-based medicine and advanced diagnostics, focusing on healthspan extension, cellular health, and preventive aging care.
Personalized Wellness Care
We deliver data-driven, individualized wellness plans tailored to each person’s biology, lifestyle, and long-term health goals for measurable outcomes.
Gplife Healthcare is dedicated to supporting a healthier, more balanced lifestyle. We believe wellness is not just a goal, but a way of living. Our focus is on encouraging positive habits, mindful living, and overall well-being in everyday life.
At Gplife Healthcare, we curate wellness-focused products and solutions that support a healthy balance of mind, body, and lifestyle.
All our products are researched and manufactured by Gplife Healthcare Pvt. Ltd.
Global RecognitionGPLIFE HEALTHCARE
The Healthcare Revolution: Exclusive Innovation and Research in Diabetes Mellitus
Dr. Chetan Savaliya and Manish Ray, Directors of Gplife Healthcare Pvt. Ltd., received this recognition at the Glorious Golden Jubilee Awards held at the House of Lords, London, in 2023. The published event report identifies the award title and recipients.
Verification source: Asian Voice — House of Lords Award Report
Forbes India — GPLIFE Healthcare Feature
Gplife Healthcare was featured in a Forbes India Brand Connect publication discussing its plant-based healthcare approach, research, botanical active-causality concept, clinical work and international ambitions.
Verification source: Forbes India Brand Connect Feature
International Scientific Representation — Dalian, China
The official 2019 Regenerative Medicine & Stem Cell conference programme lists Dr. Shridhar J. Pandya, Managing Director of Gplife Healthcare Pvt. Ltd., as Co-Chair of the Stem-Cell Therapy of Diabetes session and lists his Gplife diabetes research presentation.
Verification source: Official RMSC 2019 Conference Programme
AYUSHEXCIL Membership / RCMC
The Ayush Export Promotion Council member document lists Gplife Healthcare Private Limited under Ayurvedic Proprietary Medicine and Nutraceutical, with RCMC/AYUSHEXCIL/00048/2023-2024.
Verification source: Official AYUSHEXCIL Member Document
Internationally Indexed Clinical Research — Type 2 Diabetes
A Gplife-affiliated research team including Dr. Shridhar Pandya, Dr. Chetan Savaliya and Dr. Dheeraj Nagore published clinical research on a standardized polyherbal formulation in Type 2 diabetes. The study is indexed in PubMed.
Verification source: PubMed — Clinical Research Record
International Scientific Leadership — Dr. Shridhar J. Pandya
Dr. Shridhar J. Pandya represented Gplife Healthcare at the 2019 Dalian regenerative medicine congress; the official programme records his role as Co-Chair for the Stem-Cell Therapy of Diabetes session.
Verification source: Official RMSC 2019 Programme
DPIIT Recognised Startup — Government of India
Gplife Healthcare Private Limited is listed in current company information as a DPIIT-recognised startup.
Verification source: Government of India — DPIIT, Startup India